Roche receives positive CHMP opinion for Evrysdi, the first and only...
Roche receives positive CHMP opinion for Evrysdi, the first and only at home spinal muscular atrophy (SMA) treatment with proven efficacy in adults, children and infants two months and older Swiss Stock Exchange:RO
Medivir AB – Year-end Report January – December 2020
Medivir AB - Year-end Report January - December 2020
Molecular Partners Publishes Audited Financial Results for 2020 and Annual Report...
Molecular Partners Publishes Audited Financial Results for 2020 and Annual Report 2020
Daiichi Sankyo and LYSA-LYSARC-CALYM Enter Research Collaboration for Valemetostat in Patients...
Daiichi Sankyo and LYSA-LYSARC-CALYM Enter Research Collaboration for Valemetostat in Patients with Relapsed/Refractory B-Cell Lymphoma - FirstWord Pharma
